10 For 10: Top Compliance Stories For the Week Ending, August 2, 2025
Daily Compliance News: July 30, 2025, The Corruption Kill Business Edition
Investment Opportunities in Italy's Tech Market
Exploring Employment Law Across Borders: Italy vs. US With White Lotus — Hiring to Firing Podcast
Life with GDPR - Clearview AI Redux
Energy Horizons: Developing solar in Italy – key insights and practical market considerations
JONES DAY TALKS®: Private Antitrust Litigation in Italy
Jones Day Talks: Italy Embraces Foreign investment but Maintains Oversight
In Europe, the regulation of pricing and reimbursement for medicinal products is primarily governed by national policies, as EU-level regulation is limited. Our latest brochure “Market Access in Europe: Navigating Pricing &...more
By order issued on June 18, 2017, in summary proceedings brought by Teva against Mylan and Synthon for the alleged infringement of EP 2 361 924 (covering a manufacturing process for the active ingredient glatiramer acetate),...more
On 19 January 2017, the Italian Competition Authority (AGCM) and the Italian Medicines Agency (AIFA) signed a memorandum of understanding in order to increase enforcement in the pharmaceutical sector by strengthening their...more